Volume 14, Number 3Review ArticlesNocturia: Focus on Etiology and ConsequencesDisease State ReviewJeffrey P WeissNocturia is a condition characterized by the need to awaken ≥ 1 times per night to void. Although nocturia is a multifactorial condition that can coexist with other lower urinary tract symptoms, the most common causal factor is nighttime overproduction of urine. Many people with nocturia do not seek help, accepting it as a natural consequence of aging. However, nocturia is common in men and women of all ages and has a profound impact on quality of life, especially in the young, that may be associated with increased morbidity and mortality. Nocturia as a condition deserves public health attention. [Rev Urol. 2012;14(3/4):48-55 doi: 10.3909/riu0576] © 2013 MedReviews®, LLCNocturiaQuality of lifeSleep disruptionNighttime urine overproduction
Volume 20, Number 4Case ReviewNocturia: Finding an IdentityBenjamin M BruckerNocturia is a condition that has a tremendous impact on a patient’s health and wellbeing. Getting up 2 or more times a night to urinate fragments sleep, preventing deep, restorative stages of the sleep cycle. With safer and more effective therapies, nocturia is a treatable condition that no longer should be overlooked. The simplicity of directly targeting the cause of nocturia, the overproduction of urine (ie, nocturnal polyuria) should be considered. Noctiva™ (desmopressin acetate) nasal spray (Avadel Pharmaceuticals plc, Chesterfield, MO), a novel FDA-approved microdose desmopressin nasal spray, can reduce nighttime urine production and potentially mitigate the potential harm of nocturia. [Rev Urol. 2018;20(4):170–173 doi: 10.3909/riu0822] © 2019 MedReviews®, LLCQuality of lifeBPHLower urinary tract symptoms (LUTS)Desmopressin acetate